期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
分散药起爆方式控制FAE燃料分散的数值模拟 被引量:4
1
作者 肖绍清 白春华 +2 位作者 王小华 戴碧勇 丁儆 《火炸药学报》 CAS CSCD 2001年第1期24-26,23,共4页
为初步预示燃料的后期分散效应 ,运用 ANSYS/ DYNA3D程序 ,选择了四种起爆方式数值模拟分散药对 FAE炸弹壳体起始阶段的破裂及运动过程。结果表明 ,分散药起爆方式即爆轰波传播方向对燃料分散有显著的影响 ,因此 ,分散药起爆方式在
关键词 燃料空气炸 爆轰波传播方向 燃料分散 分散药 起爆方式 FAE 数值模拟
下载PDF
分散药T型装药控制二次引爆型FAE云雾研究 被引量:10
2
作者 肖绍清 《火炸药学报》 EI CAS CSCD 2006年第2期10-14,共5页
为了控制新型FAE弹体云雾的窜火、形状、直径与高度等,设计出直径不同的两种药柱间隔装填的分散药T型装药结构,着重对两种药柱的半径、高度、爆速、密度、分散药燃料比进行了设计。在假设小药柱以平面爆轰波引爆大药柱的前提下,对大药... 为了控制新型FAE弹体云雾的窜火、形状、直径与高度等,设计出直径不同的两种药柱间隔装填的分散药T型装药结构,着重对两种药柱的半径、高度、爆速、密度、分散药燃料比进行了设计。在假设小药柱以平面爆轰波引爆大药柱的前提下,对大药柱爆轰波正常传播条件进行了理论推导。选择宏观固态燃料,对Φ330mm×430mm的新型FAE炸弹进行静爆实验;运用柯达高速运动系统观测云雾形成及爆轰过程,并对FAE云雾的直径、高度和体积进行了处理和分析。结果表明,分散药T型装药能有效地控制FAE云雾的形状、直径、高度以及云雾体积,特别是对遏制云雾窜火有很好的效果。 展开更多
关键词 爆炸力学 FAE云雾 分散药 T型装 二次引爆
下载PDF
复合分散药的性能及对FAE燃料分散的影响 被引量:2
3
作者 肖绍清 《含能材料》 EI CAS CSCD 2006年第4期244-247,256,共5页
设计了一种新型结构的复合分散药,用以取代常规燃料空气炸药(FAE)分散药,对复合分散药爆轰波传播模型、装药结构尺寸、芯药和外层炸药爆速、复合分散药占燃料质量分数对FAE爆炸云雾的形成和传播进行了分析研究。在此基础上,进行了以压... 设计了一种新型结构的复合分散药,用以取代常规燃料空气炸药(FAE)分散药,对复合分散药爆轰波传播模型、装药结构尺寸、芯药和外层炸药爆速、复合分散药占燃料质量分数对FAE爆炸云雾的形成和传播进行了分析研究。在此基础上,进行了以压装密度为1.72 g.cm-3、爆速为8400 m.s-1的8701炸药为芯药,以低密度硝基胍(NQ)为外层炸药,以环氧丙烷(PO)和宏观固态燃料为FAE燃料分散与引爆实验。结果表明,采用复合分散药,分散药燃料比超过1.3%,云雾未发生窜火,云雾形状基本为类草帽形,并可靠爆轰,这说明采取复合装药结构是完全可行的。 展开更多
关键词 爆炸力学 燃料空气炸(FAE) 复合分散药 爆轰波 传播方向 燃料分散 控制
下载PDF
阻燃介质在炸药驱动燃料分散中的应用 被引量:4
4
作者 王永旭 解立峰 +2 位作者 贾晓亮 张莹 李斌 《爆炸与冲击》 EI CAS CSCD 北大核心 2020年第4期51-58,共8页
为解决燃料空气炸药中的燃料在中心分散装药爆炸驱动抛撒过程中易发生的窜火问题,结合中心分散装药结构设计,引入以超细干粉灭火剂为主体的阻燃介质,采用高速录像和红外热成像仪研究了中心分散药外部填充阻燃介质的情况下,对中心分散药... 为解决燃料空气炸药中的燃料在中心分散装药爆炸驱动抛撒过程中易发生的窜火问题,结合中心分散装药结构设计,引入以超细干粉灭火剂为主体的阻燃介质,采用高速录像和红外热成像仪研究了中心分散药外部填充阻燃介质的情况下,对中心分散药爆炸火球产生的高温及火焰的抑制情况。试验结果表明,中心分散药爆炸火球的最高温度为1 355.4℃,温度超过150℃的持续时间为264.8 ms。外部填充阻燃介质后,中心分散药爆炸产生的火焰基本消失,火球最高温度下降90%以上,火球表面温度分布不超过100℃。同时进行了验证试验,采用填充阻燃介质的中心分散药抛撒1 kg的乙醚和铝粉的混合燃料,分散药与燃料的质量比超过4%时,云雾仍未发生窜火。表明填充阻燃介质可以有效防止燃料在爆炸抛撒过程中发生窜火的问题。 展开更多
关键词 燃料空气炸 分散药 窜火 阻燃介质
下载PDF
基质分离固相萃取-液相色谱-串联质谱法快速测定牛肉中4种β_2-受体激动剂类兽药残留 被引量:3
5
作者 王莉莉 陈雪营 +7 位作者 张楠 刘平 刘伟 李丽萍 吴国华 赵榕 范赛 闫薪竹 《食品安全质量检测学报》 CAS 北大核心 2021年第11期4647-4653,共7页
目的建立基质分离固相萃取结合液相色谱串联质谱法(liquidchromatographytandemmass spectrometry, LC-MS/MS)快速测定牛肉中克伦特罗、莱克多巴胺、沙丁胺醇、特布他林等4种β_(2)-受体激动剂类兽药残留。方法样品经葡萄糖醛苷酶/硫酸... 目的建立基质分离固相萃取结合液相色谱串联质谱法(liquidchromatographytandemmass spectrometry, LC-MS/MS)快速测定牛肉中克伦特罗、莱克多巴胺、沙丁胺醇、特布他林等4种β_(2)-受体激动剂类兽药残留。方法样品经葡萄糖醛苷酶/硫酸酯酶酶解、盐析后经CNW兽药定量检测分散固相萃取纯化包净化。采用LC-MS/MS电喷雾正离子模式、多反应监测采集(multiple reaction monitoring acquisition, MRM)测定。结果当4种β_(2)-受体激动剂类兽药化合物空白样本加标水平在2.5、12.5、50μg/kg时,回收率为95.39%~106.59%,相对标准偏差(relative standard deviation, RSD)为0.98%~13.26%。4种目标化合物的检出限为0.1~0.3μg/kg,定量限为0.3~1.0μg/kg。针对市售66件牛肉样品中目标化合物进行检测,结果均未检出。结论与传统通过性固相萃取法相比,兽药定量检测分散固相萃取纯化法净化效果更好,基质效应更低。CNW兽药定量检测分散固相萃取法可用于牛肉中克伦特罗、莱克多巴胺、沙丁胺醇、特布他林4种β_(2)-受体激动剂类兽药残留快速检测。 展开更多
关键词 β_2-受体激动剂类兽 液相色谱-串联质谱法 CNW兽定量检测分散固相萃取纯化包
下载PDF
提高金堆城钼矿选铜回收率的试验研究 被引量:10
6
作者 杜新路 程景峰 +1 位作者 张攀 洪养军 《中国钼业》 2006年第1期20-22,共3页
通过对新型选矿药剂T-2K在金堆城钼矿选铜试验研究中表明:T-2K在铜硫分离中具有较低的pH分选性,对铜矿物选择性非常好。在不使用活化剂的闭路试验中,原矿品位0.77%,精矿品位22.72%,回收率达到93·10%,取得了满意的效果。
关键词 选矿 T-2K 分散 流程结构 闭路试验
下载PDF
Determination of Piperazine Ferulate in Human Plasma by HPLC and Its Pharmacokinetic Study 被引量:1
7
作者 袁桂艳 王本杰 +2 位作者 魏春敏 刘焕君 郭瑞臣 《Journal of Chinese Pharmaceutical Sciences》 CAS 2006年第4期238-242,共5页
Aim To establish a sensitive HPLC method for determination of piperazine ferulate and to study its pharmacokinetics in healthy volunteers. Methods Piperazine ferulate was separated on a Shimadzu C_ 18 column with acet... Aim To establish a sensitive HPLC method for determination of piperazine ferulate and to study its pharmacokinetics in healthy volunteers. Methods Piperazine ferulate was separated on a Shimadzu C_ 18 column with acetic acid (0.1%)-methanol (60 ∶ 40, V/V) as mobile phase after liquid-liquid extraction, and detection was performed at 310 nm. Piperazine ferulate pharmacokinetic parameters after a single oral dose of 200 mg of piperazine ferulate dispersible tablets in 20 healthy male volunteers were calculate... 展开更多
关键词 piperazine ferulate dispersible tablet PHARMACOKINETICS HPLC
下载PDF
Preparation,physicochemical characterization and cyctotoxicity of solid dispersion of paclitaxel and polyvinylpyrrolidone 被引量:2
8
作者 孙葭北 刘祥瑞 +3 位作者 王坚成 吕万良 张炬 张强 《Journal of Chinese Pharmaceutical Sciences》 CAS 2008年第2期113-117,共5页
The objective of this study was to prepare and characterize paclitaxel-polyvinylpyrrolidone (PTX-PVP) solid dispersions with the intention of improving its solubility and dissolution properties. The PTX-PVP solid di... The objective of this study was to prepare and characterize paclitaxel-polyvinylpyrrolidone (PTX-PVP) solid dispersions with the intention of improving its solubility and dissolution properties. The PTX-PVP solid dispersion systems were prepared by solvent method. The release rate ofpaclitaxel was determined from dissolution studies and the physicochemical properties of solid dispersion were investigated by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM). The cytotoxicities ofpaclitaxel in solid dispersion to the SKOV-3 cells were assayed by a SRB staining method. The results showed that the solubility and dissolution rate of paclitaxel were significantly improved in solid dispersion system compared with that of the pure drug and physical mixture. The results of DSC and PXRD showed that the paclitaxel in solid dispersion was amorphous form. No paclitaxel crystals in the solid dispersions was found during SEM analysis. Cytotoxicity study suggested that the inhibitory rates of PTX-PVP solid dispersion to SKOV-3 cells were higher than that of pure paclitaxel. The solubility and dissolution of paclitaxel were improved by solid dispersion technique. In vitro cytotoxicity of paclitaxel in solid dispersion was higher than that of pure drug. 展开更多
关键词 PACLITAXEL POLYVINYLPYRROLIDONE Solid dispersion SOLUBILITY Dissolution rate Cytotoxicity assay
下载PDF
通滞苏润江胶囊治疗腰椎间盘突出症的临床观察 被引量:6
9
作者 李欣艳 《吉林医学》 CAS 2019年第1期86-87,共2页
目的:观察通滞苏润江胶囊治疗腰间盘突出症的临床疗效。方法:选择符合要求的腰间盘突出症患者96例,随机分为两组各48例。对照组采用口服非甾体消炎药+甲钴胺分散片治疗,治疗组采用在对照组的基础上加服通滞苏润江胶囊,5粒/次,2次/d。结... 目的:观察通滞苏润江胶囊治疗腰间盘突出症的临床疗效。方法:选择符合要求的腰间盘突出症患者96例,随机分为两组各48例。对照组采用口服非甾体消炎药+甲钴胺分散片治疗,治疗组采用在对照组的基础上加服通滞苏润江胶囊,5粒/次,2次/d。结果:治疗组总有效率100%,明显高于对照组83. 3%,差异有统计学意义。结论:通滞苏润江胶囊复合非甾体消炎药+甲钴胺分散片治疗腰间盘突出疗效显著,值得推广。 展开更多
关键词 通滞苏润江胶囊 非甾体消炎+甲钴胺分散 腰椎间盘突出
下载PDF
Dissolution Improvement of Cisapride by Solid Dispersion with HPMC
10
作者 魏振平 毛世瑞 +1 位作者 毕殿洲 李勇 《Journal of Chinese Pharmaceutical Sciences》 CAS 2004年第4期254-258,共5页
To prepare a solid dispersion of cisapride with hydroxypropylmethyl cellulose(HPMC E5 LV) as carrier for the purpose of accelerating the in vitro drug release by means ofimproving the solubility of the model drug. Met... To prepare a solid dispersion of cisapride with hydroxypropylmethyl cellulose(HPMC E5 LV) as carrier for the purpose of accelerating the in vitro drug release by means ofimproving the solubility of the model drug. Methods Alcohol and simulated gastric fluid (SGF) wereused to dissolve cisapride and HPMC in order to make the model drug dispersed homogeneously in thecarrier. The HPMC-cisapride solid dispersion was then obtained by conventional solvent evaporationmethod. Powder X-ray diffraction (XRD) was used to measure the diffraction peaks of pure carrier,pure cisapride, physical mixture of HPMC with cisapride (4:1), and HPMC-cisapride solid dispersion(4:1) to confirm the crystal existence. The solubility of pure drug and HPMC-cisapride soliddispersion was measured with water, SGF and simulated intestinal fluid (SIF) . The in vitro drugreleases of the sustained release tablet prepared with pure cisapride or HPMC-cisapride soliddispersion were investigated with water and SGF as media, respectively. Results No diffraction peakswere found by X-ray diffraction in the HPMC-cisapride solid dispersion (4:1), indicating that thedrug existed in an amorphous form at that drug-carrier ratio. Compared with the pure drug, thesolubilities of HPMC-cisapride solid dispersion are increased by 239.4% in SGF, 132.6% in water, and117.9% in SIF. According to the in vitro drug release, the sustained release tablet prepared withHPMC-cisapride solid dispersion had a faster drug release than did that prepared with pure drug. Thein vitro drug release profiles were found to comply with Higuchi's rule. Conclusion The in vitrodrug release of the sustained release tablet made by HPMC-cisapride solid dispersion is improvedowing to the increased drug solubility. 展开更多
关键词 CISAPRIDE HPMC E5 LV solid dispersion
下载PDF
Effective recovery of chalcopyrite at low temperatures using modified ester collector 被引量:4
11
作者 Xian-zhong BU Yuan-yuan FENG +2 位作者 Ji-wei XUE Lu YANG Chong-hui ZHANG 《Transactions of Nonferrous Metals Society of China》 SCIE EI CAS CSCD 2022年第1期296-306,共11页
The effect of a modified ester collector named as BL on the flotation of chalcopyrite at low temperatures was investigated by micro-flotation tests,contact angle measurements,adsorption experiments,laser particle size... The effect of a modified ester collector named as BL on the flotation of chalcopyrite at low temperatures was investigated by micro-flotation tests,contact angle measurements,adsorption experiments,laser particle size analysis,cryogenic transmission electron microscopy(Cryo-TEM)and Fourier transform infrared(FTIR)analyses.Micro-flotation tests proved that the collecting ability of BL for chalcopyrite was significantly better than that of N,N-diethyl dithiocarbamate propiononitrile ester(ester-105)at low temperatures.Combined with laser particle size,Cryo-TEM and FTIR analyses,it was found that the particle size of BL in water was smaller than that of ester-105,and the distributed density of BL was higher than that of ester-105 at low temperatures,indicating that BL dispersed well at low temperatures.Therefore,BL was more easily adsorbed on the chalcopyrite surface and improved the surface hydrophobic degree of chalcopyrite,which were also confirmed by the contact angle measurements and adsorption experiments. 展开更多
关键词 modified ester collector chalcopyrite flotation collecting ability DISPERSIVITY low temperature reagent synthesis
下载PDF
Molecular Biological Mechanisms of Yuan Zhi Powder in the Treatment of Alzheimer's Disease: an Analysis Based on Network Pharmacology 被引量:9
12
作者 Wei-Jie QIANG Ying CHEN +9 位作者 Fu-Yuan HE Mei-Feng XIAO Wei-Yan CAI Yi-Fei DAI Qing YANG Yu-Jie LI Xiao-Gang WENG Qi LI Ya-Jie WANG Xiao-Xin ZHU 《Digital Chinese Medicine》 2018年第1期90-101,共12页
Objective To predict the main active ingredients,potential targets and molecular mechanisms of Yuan Zhi powder in treatment of dementia by using network pharmacology.Methods A database of chemical constituents of Yuan... Objective To predict the main active ingredients,potential targets and molecular mechanisms of Yuan Zhi powder in treatment of dementia by using network pharmacology.Methods A database of chemical constituents of Yuan Zhi powder was constructed by using databases and literatures.Potential targets were predicted by reverse molecular docking,and then a component-target network was constructed.The target network of Alzheimer's disease(AD)was mapped and analyzed to obtain the“active ingredient-AD target”network.The key targets were screened through network analysis.Finally,the rationality of the prediction was analyzed by comparing with the target reported in the literatures.Results There were180chemical constituents acting on the AD target,and the targets included three key targets(cyclooxygenase-2,muscarinic acetylcholine receptor M1,and muscarinic acetylcholine receptor M2)and an important target(acetylcholine esterase).Alzheimer's disease may be treated by regulating the activity of acetylcholine receptors and the binding toβ-amyloid protein,and its biological process may be concentrated in the acetylcholine receptor signal pathway,negative regulation of synaptic transmission and so on.Conclusion The fact that Yuan Zhi powder can treat AD is consistent with the characteristics of multi-components-multitargets-multiple pathways of traditional Chinese medicine.The important targets obtained from network analysis have a large proportion in literature research,so network analysis have some rationality. 展开更多
关键词 Yuan Zhi powder Network pharmacology Active ingredients–AD targets network Network analysis DEMENTIA
下载PDF
超滤在药学分析测定中的应用 被引量:6
13
作者 徐缓 张伟 邓意辉 《药物分析杂志》 CAS CSCD 北大核心 2013年第5期717-723,共7页
超滤是在压力作用下,溶剂与部分低相对分子质量溶质可以穿过超滤膜,而高相对分子质量溶质或乳化胶束等被截留的一种分离手段。作为一种新型膜分离技术,超滤以其独特的优势在药学分析测定中得到广泛应用。本文主要针对超滤在微粒分散给... 超滤是在压力作用下,溶剂与部分低相对分子质量溶质可以穿过超滤膜,而高相对分子质量溶质或乳化胶束等被截留的一种分离手段。作为一种新型膜分离技术,超滤以其独特的优势在药学分析测定中得到广泛应用。本文主要针对超滤在微粒分散给药系统、生物制药、高分子的分离纯化、表面活性剂临界胶束浓度测定等方面的应用进行综述。 展开更多
关键词 超滤 膜分离技术 学分析测定 微粒分散系统 生物制 高分子分离纯化 表面活性剂临界胶束浓度 截留分子量
原文传递
Fatal accident due to anti-personnel ARGES EMO1 rifle grenade explosion
14
作者 Pavlos Pavlidis Valeria Karakasi Theodossios A. Birbilis 《Chinese Journal of Traumatology》 CAS CSCD 2016年第3期136-138,共3页
During the process of unsealing an old ammunition box in order to destroy it, a 42-year-old ammunition technician was fatally injured due to an anti-personnel ARGES EM01-type rifle grenade detonation. The explosion to... During the process of unsealing an old ammunition box in order to destroy it, a 42-year-old ammunition technician was fatally injured due to an anti-personnel ARGES EM01-type rifle grenade detonation. The explosion took place in the victim's hands, in point-blank range. This report aimed to show the anatomical position, the severity and the dispersion extent of the multiple injuries in the human body due to the detonation, and draw firm conclusions regarding the position of the human body and the circumstances prevailing at the moment of the explosion. 展开更多
关键词 Wounds and injuriesRifle grenadeAccidentsForensic pathology
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部